Specialty Surgical Oncology Raises $2.8 Million—Founder Says No Patient Should Be Denied Care

StartUp News Desk

A pioneering cancer hospital in India is making waves in healthcare. Specialty Surgical Oncology (SSO) has raised $2.8 million to expand its life-saving services, with founder Dr. Sanket Mehta emphasizing a bold principle: income should never decide a patient’s fate.

Since its founding in 2021, SSO has been tackling critical gaps in cancer surgery—offering advanced care that was often unavailable in overcrowded hospitals.


A Mission Born from Need

Filling a Critical Gap

SSO was founded by a team of seven cancer surgeons led by Dr. Mehta, a Tata-trained oncology expert. They recognized that many complex surgeries were being performed by general surgeons without access to advanced resources, leading to compromised outcomes.

Dedicated Cancer Care

SSO focuses on organ-specific surgical teams and facilities dedicated solely to cancer surgeries, ensuring patients receive specialized, high-quality care.


Growth and Impact

Expanding Footprint

Since 2021, SSO has grown to five centres across India and employs a team of 20 surgeons, all highly trained in complex oncology procedures.

Remarkable Track Record

Collectively, the surgeons at SSO have performed over 20,000 complex oncology procedures, making the hospital a trusted name for patients seeking advanced cancer treatment.


Founder’s Vision

Dr. Sanket Mehta’s guiding philosophy is simple yet powerful: healthcare should be accessible to all, regardless of income. He says SSO’s model demonstrates that high-quality, specialized cancer care can be both effective and equitable.

“This is not just about surgeries—it’s about giving patients hope and ensuring that financial barriers never stand in the way of treatment,” Dr. Mehta says.


Why This Funding Matters

The recent $2.8 million funding will allow SSO to:

  • Expand to more centres across India
  • Invest in cutting-edge surgical technologies
  • Grow their team of specialized oncology surgeons

This means more patients will have access to dedicated, life-saving cancer care without compromising on quality or affordability.


Specialty Surgical Oncology is redefining cancer care in India. With dedicated organ-specific surgical teams, five centres, and a commitment to equitable treatment, SSO proves that income should never determine a patient’s survival.

The $2.8 million funding is just the beginning—SSO is on a mission to make world-class cancer surgery accessible to all, setting a new standard for healthcare in India.

Share This Article
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *